The Singapore Eye Research Institute (SERI) was conceived with the foresight of a visionary leader, Prof Arthur Lim, the founder and first Medical Director of the Singapore National Eye Centre (SNEC), who had keenly pursued the idea of an eye research institute in a period of time when research was hardly in vogue in Singapore.
Established in 1997, SERI is Singapore’s national research institute for ophthalmic and vision research. SERI’s mission is to conduct high impact eye research with the aim to prevent blindness, low vision and major eye diseases common to Singaporeans and Asians. Over the last decade or so, SERI has conducted landmark research that has led to tangible outcomes, actual patient benefit, and success stories. It has paved the way for significant improvements in how eye diseases are treated and prevented, not just for Singaporeans or Asians but on a global scale.
At its inception, SERI saw a national remit in ophthalmic and vision research, and till today, despite the demarcations introduced by the healthcare clustering system, SERI bridges the clusters with a presence in each cluster. SERI ensures that its facilities and resources are open to researchers across Singapore so that the greatest benefit may be obtained from what is a relatively small clinical ophthalmology catchment area in Singapore.
SERI has grown from a founding team of five in 1997 to a faculty of more than 220, encompassing clinician scientists, scientists, research fellows, PhD students and support staff. This makes SERI one of the largest research institutes in Singapore and the largest eye research institute in Asia-Pacific. In addition, SERI has over 100 adjunct faculties from various eye departments, biomedical institutes and tertiary centres in Singapore. SERI has amassed an impressive array of publications totaling 2,700 scientific papers as of January 2017, and has secured 252 external peer-reviewed competitive grants worth more than $227 million. To date, as of January 2017, SERI’s faculty has been awarded more than 400 national and international prizes and filed 105 patents. Serving as the research institute of the Singapore National Eye Centre, and directly affiliated to the Yong Loo Lin School of Medicine, National University of Singapore, as well the Duke-NUS Medical School, SERI undertakes vision research in collaboration with local clinical ophthalmic centres and biomedical research institutions, as well as major eye centres and research institutes throughout the world.
SERI is proud to rank above the global heavyweights, i.e. Singapore is Impact number one globally in terms of eye publications per capita, far ahead of the US, UK and Japan.
With its impressive publication track record, SERI is comparable to renowned eye institutes, both regionally and internationally.